SOLV Solventum Corporation

NYSE · US · Healthcare · Medical Instruments & Supplies · solventum.com

88.03USD+0.20%Mkt Cap: 14.98B $P/E: 10.771d ago

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates throug…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap14.98B USD

Enterprise Value19.85B USD

Revenue (TTM)8.31B USD

Gross Profit4.45B USD

Net Income (TTM)1.56B USD

Revenue/Share47.79 USD

Last Price88.03 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees20.6K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)10.77

P/E (Forward)12.15

PEG1.22

EV/EBITDA17.42

EV/Revenue2.39

P/S1.80

P/B3.11

EPS (TTM)8.17

EPS (Forward)7.23

52W Range

62.3881% of range94.16

52W High94.16 USD

52W Low62.38 USD

Profitability

Gross Margin53.47%

Oper. Margin9.78%

EBITDA Margin13.71%

Profit Margin18.69%

ROE30.81%

ROA10.89%

Growth

Revenue Growth2.20%

Earnings Growth3.90%

Cash Flow & Leverage

Operating CF369.00M USD

CapEx (TTM)379.00M USD

FCF Margin5.88%

FCF Yield3.26%

Net Debt4.89B USD

Net Debt/EBITDA4.29

Balance Sheet

Debt/Equity1.00

Current Ratio1.02

Quick Ratio0.50

Book Value/Sh28.22 USD

Cash/Share2.37 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)93.92 USD

Upside (mean)+6.7%

Target Range70.00 USD – 113.00 USD

70.00+6.7% to mean113.00

# Analysts13

Ownership

Shares Out.170.22M

Float144.09M

Insiders15.34%

Institutions75.88%

Short Interest

Short Ratio5.3d

Short % Float3.37%

Short % Out.2.86%

Shares Short4.86M

Short (prev mo.)3.47M

Technical

SMA 5088.13 (-0.1%)

SMA 20077.95 (+12.9%)

Beta0.69

S&P 52W Chg14.58%

Avg Vol (30d)866.80K

Avg Vol (10d)723.88K

Technical Indicators

RSI (14)47.2

MACD0.0185

MACD Signal0.3273

MACD Hist.-0.3088

BB Upper91.12 USD

BB Middle88.92 USD

BB Lower86.72 USD

BB Width4.95%

ATR (14)1.904 USD

Vol Ratio (20d)1.18x